Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1992 | 03-1992 | 12-1991 | 09-1991 | 06-1991 | |
| Sales | 754 | 823 | 664 | 464 | 564 |
| Cost of Goods | 349 | 445 | 408 | 338 | 389 |
| Gross Profit | 400 | 370 | 256 | 127 | 175 |
| Operating Expenses | 774 | 937 | 831 | 941 | 891 |
| Operating Income | -20 | -114 | -167 | -477 | -327 |
| Interest Expense | 0 | 6 | 9 | 5 | 6 |
| Other Income | 0 | 0 | -23 | 16 | 29 |
| Pre-tax Income | -20 | -120 | -199 | -466 | -304 |
| Net Income Continuous | -20 | -119 | -199 | -466 | -304 |
| Net Income Discontinuous | 0 | -1,998,000 | N/A | 0 | 0 |
| Net Income | $-20 | $-119 | $-199 | $-466 | $-304 |
| EPS Basic Total Ops | -0.01 | -0.06 | N/A | -0.23 | -0.15 |
| EPS Basic Continuous Ops | -0.01 | -0.06 | N/A | -0.23 | -0.15 |
| EPS Basic Discontinuous Ops | N/A | -1,003.01 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.01 | -0.06 | -0.10 | -0.23 | -0.15 |
| EPS Diluted Continuous Ops | -0.01 | -0.06 | -0.10 | -0.23 | -0.15 |
| EPS Diluted Discontinuous Ops | N/A | -1,003.01 | N/A | N/A | N/A |
| EBITDA(a) | $-20 | $-114 | $-167 | $-477 | $-327 |